His primary areas of investigation include Anesthesia, Psychiatry, Addiction, Substance abuse and Methadone. Thomas R. Kosten has included themes like Cocaine dependence, Randomized controlled trial, Buprenorphine, Placebo and Abstinence in his Anesthesia study. His Psychiatry study integrates concerns from other disciplines, such as Treatment outcome and Clinical psychology.
His studies in Addiction integrate themes in fields like Bioinformatics, Anxiety, Tiagabine, Opiate and Depression. His work deals with themes such as Vulnerability, Methamphetamine, Psychometrics and Drug, which intersect with Substance abuse. His Methadone research includes elements of Internal medicine, Urine and Opioid.
His primary areas of study are Psychiatry, Internal medicine, Anesthesia, Addiction and Methadone. His research links Clinical psychology with Psychiatry. Thomas R. Kosten has researched Internal medicine in several fields, including Endocrinology, Oncology, Genotype and Schizophrenia.
His research integrates issues of Clinical trial, Cocaine dependence, Randomized controlled trial, Placebo and Abstinence in his study of Anesthesia. As part of the same scientific family, he usually focuses on Placebo, concentrating on Pharmacology and intersecting with Pharmacogenetics. His Methadone research is multidisciplinary, incorporating elements of Buprenorphine and Desipramine.
Thomas R. Kosten mainly focuses on Psychiatry, Internal medicine, Placebo, Addiction and Opioid use disorder. His work carried out in the field of Psychiatry brings together such families of science as Cannabinoid, MEDLINE and Clinical psychology. His Internal medicine research incorporates themes from Endocrinology, Oncology, Genotype and Positive and Negative Syndrome Scale.
His Placebo study combines topics in areas such as Anesthesia, Agonist, Randomized controlled trial, Cocaine dependence and Abstinence. Thomas R. Kosten focuses mostly in the field of Addiction, narrowing it down to topics relating to Substance abuse and, in certain cases, Drug. His work in Opioid use disorder covers topics such as Buprenorphine which are related to areas like Methadone, Medical prescription, Naloxone and Pharmacotherapy.
His main research concerns Psychiatry, Schizophrenia, Positive and Negative Syndrome Scale, Internal medicine and Addiction. In general Psychiatry study, his work on Methadone often relates to the realm of Knowledge infrastructure, thereby connecting several areas of interest. His Schizophrenia research incorporates themes from Clinical psychology and Adjunctive treatment.
His work carried out in the field of Positive and Negative Syndrome Scale brings together such families of science as Genetics, Lipid profile, Protective factor, Psychopathology and Repeatable Battery for the Assessment of Neuropsychological Status. His Internal medicine research focuses on subjects like Endocrinology, which are linked to Gene polymorphism, Genotype and Brain-derived neurotrophic factor. The various areas that Thomas R. Kosten examines in his Addiction study include Coping behavior, Immunology, Intensive care medicine, Substance use and Pandemic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature
Leslie K. Jacobsen;Steven M. Southwick;Thomas R. Kosten.
American Journal of Psychiatry (2001)
Neurobiological similarities in depression and drug dependence : A self-medication hypothesis
Athina Markou;Thomas R. Kosten;George F. Koob.
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
Bridget A. Martell;Patrick G. O'Connor;Robert D. Kerns;William C. Becker.
Annals of Internal Medicine (2007)
Management of drug and alcohol withdrawal.
Thomas R. Kosten;Patrick G. O'Connor.
The New England Journal of Medicine (2003)
Urinary free-cortisol levels in posttraumatic stress disorder patients.
John W. Mason;Earl L. Giller;Thomas R. Kosten;Robert B. Ostroff.
Journal of Nervous and Mental Disease (1986)
The Neurobiology of Opioid Dependence: Implications for Treatment
Thomas R Kosten;Tony P George.
Science & Practice Perspectives (2002)
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.
Bruce J. Rounsaville;Thomas R. Kosten;Myrna M. Weissman;Herbert D. Kleber.
Archives of General Psychiatry (1986)
Desipramine facilitation of initial cocaine abstinence.
Frank H. Gawin;Herbert D. Kleber;Robert Byck;Bruce J. Rounsaville.
Archives of General Psychiatry (1989)
Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder
Thomas R. Kosten;John W. Mason;Earl L. Giller;Robert B. Ostroff.
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
Tony P. George;Douglas M. Ziedonis;Alan Feingold;W. Thomas Pepper.
American Journal of Psychiatry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: